LIVN News and Press, LivaNova PLC From 11/30/22

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced its participation in the American Epilepsy Society (AES) 2022 Annual Meeting, taking place December 2-6 in Nashville, Tennessee. The Company’s therapies and technologies will be feature...

Platform simplifies life support, making life-saving technology more accessible to hospitals and critically ill patients LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received 510(k) clearance for extracorporeal m...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced its Chief Executive Officer Damien McDonald will present a general business update during fireside chats at three healthcare conferences in New York this month: Stifel Healthca...

The following slide deck was published by LivaNova PLC in conjunction with their 2022 Q3 earnings call. For further details see: LivaNova PLC 2022 Q3 - Results - Earnings Call Presentation

LivaNova PLC (LIVN) Q3 2022 Results Earnings Conference Call November 2, 2022, 2022, 08:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development Damien McDonald - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer...

LivaNova PLC press release ( NASDAQ: LIVN ): Q3 Non-GAAP EPS of $0.58 beats by $0.03 . Revenue of $252.6M (-0.2% Y/Y) beats by $5.81M . FY2022 Outlook : The company continues to expect revenue to grow between 4% and 6% on a constant-currency basis, excludin...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended September 30, 2022. Financial Summary and Highlights 1 Revenue of $252.6 million for the quarter decreased 0.2 percent on a reporte...

Summary LivaNova is clearly doing better in weaker segments and technical profitability has actually been reached now on an operating level. Neuromodulation has been seeing slowing unit growth as seen by signs in our last coverage, but the bigger issue is that its contribution is ...

Summary David Einhorn's 13F stock portfolio value decreased from $1.57B to $1.29B this quarter. Greenlight increased Atlas Air Worldwide, Kyndryl Holdings, and Victoria’s Secret while decreasing Teck Resources, Change Healthcare, Chemours, and International Seaways. They al...

The U.S. Food and Drug Administration (FDA) on Friday classified the recall of several hundred blood bypass pump systems by LivaNova ( NASDAQ: LIVN ) as the most serious type. LivaNova ( LIVN ) in July recalled 484 LifeSPARC Systems in the U.S. distributed between Dec....